Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/11/24
End: 07/31/26
Due: 07/31/27
Phase: N/A
Priority: Normal
Start: 12/20/23
End: 06/18/24
Due: 06/18/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Open Label, Repeat Dose Study Evaluating YCT-529 in Healthy Males | NCT06542237 | YourChoice Therapeutics, Inc. | user2@example.com | None | 2024-09-11 | 2026-07-31 | 2027-07-31 | - | - | 2025-07-14 |
| First in Human Study Evaluating Single Ascending Oral Doses of YCT-529 in Healthy Males | NCT06094283 | YourChoice Therapeutics, Inc. | user2@example.com | None | 2023-12-20 | 2024-06-18 | 2025-06-18 | - | - | 2025-07-14 |